Galderma (PK)【GALDY】銘柄情報

Galderma Group AG (PK) (GALDY) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

42.76

( -1.32% )

買値

42.01

売値

43.18

出来高

42,495

平均取引量 (3 か月)

US$ 486,174

財務取引量

US$ 1,816,449

42.36 日の範囲 42.89

30.565 52 週間の範囲 46.31

時価総額

10.03B

企業価値

54.398B

前日終値

43.33

始値

42.88

時刻

124

42.76

最終取引時間

VWAP

42.745

歳入

5.24B

純利益

613M

発行済株式数

234,568,725

浮動株比率 (%)

56.55%

機関投資家保有比率 (%)

54.90%

配当利回り

0.44

PER

86.62

株価売上高倍率 (PSR)

1 株当たり利益 (EPS)

2.58

ベータ

-0.08

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland. 詳細を表示

セクター

業界

ウェブサイト

www.galderma.com

本社

Zug, Switzerland

設立

1981

Galderma Group AG (PK) is listed in the sector of the その他OTC with ticker GALDY. The last closing price for Galderma (PK) was US$43.33. Over the last year, Galderma (PK) shares have traded in a share price range of US$ 30.565 to US$ 46.31.

Galderma (PK) currently has 234,568,725 shares in issue. The market capitalisation of Galderma (PK) is US$10.03 billion. Galderma (PK) has a price to earnings ratio (PE ratio) of 86.62.

One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics

One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics PR...

The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It

Issued on behalf of Conexeu Sciences Inc. With Galderma now presenting clinical data on treating...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-1.15	-2.61899339558	43.91	44.35	42.36	59955	43.67526522	DR
4	0.07	0.16397282736	42.69	46.31	42.36	150649	43.87384083	DR
12	3.36	8.52791878173	39.4	46.31	38.45	132762	42.18799018	DR
26	1.71	4.16565164434	41.05	46.31	35.53	214967	39.62364084	DR
52	10.85	34.0018802883	31.91	46.31	30.565	158746	39.61318801	DR
156	26.11	156.816816817	16.65	46.31	15.51	94619	39.07569226	DR
260	26.11	156.816816817	16.65	46.31	15.51	94619	39.07569226	DR